Hamza O Yazdani
Overview
Explore the profile of Hamza O Yazdani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1091
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yazdani H, Yang R, Haykal T, Tohme C, Kaltenmeier C, Wang R, et al.
Transplantation
. 2024 Dec;
109(1):161-173.
PMID: 39656524
Background: Liver transplantation stands as the primary treatment for end-stage liver disease, with demand surging in recent decades because of expanded indications. However, hepatic ischemia/reperfusion injury can lead to liver...
2.
Tohme C, Haykal T, Yang R, Austin T, Loughran P, Geller D, et al.
Cells
. 2024 Sep;
13(17.
PMID: 39273020
Background: Exercise can promote sustainable protection against cold and warm liver ischemia-reperfusion injury (IRI) and tumor metastases. We have shown that this protection is by the induction of hepatic mitochondrial...
3.
Yazdani H, Geller D, Tohme S
Transplantation
. 2024 Feb;
108(3):585-587.
PMID: 38385338
Hepatic ischemia-reperfusion injury remains a significant challenge in liver transplantation potentially leading to delayed graft function, primary nonfunction, and sometimes rejection. Understanding the underlying mechanisms and implementing mitigation strategies are...
4.
Chen W, Peng W, Wang R, Bai S, Cao M, Xiong S, et al.
Cell Death Dis
. 2024 Jan;
15(1):102.
PMID: 38291031
Early metastasis is the primary factor in the very poor prognosis of pancreatic ductal adenocarcinoma (PDAC), with liver metastasis being the most common form of distant metastasis in PDAC. To...
5.
Liu Z, Annarapu G, Yazdani H, Wang Q, Liu S, Luo J, et al.
Heliyon
. 2024 Jan;
10(1):e23561.
PMID: 38187339
Diabetes mellitus (DM) poses a significant global health burden, with hyperglycemia being a primary contributor to complications and high morbidity associated with this disorder. Existing glucose management strategies have shown...
6.
Mota Alvidrez R, Annarapu G, Srinivasan A, Liu Z, Yazdani H, Nolfi-Donegan D, et al.
J Pharm Pharmacol Res
. 2023 Nov;
7(4):192-202.
PMID: 37975061
Introduction: Metformin is the most prescribed medication in Diabetes Mellitus(DM). Metformin has shown to decrease mean platelet volume, with promising antiplatelet effects. High doses of Metformin have also been associated...
7.
Mota Alvidrez R, Annarapu G, Srinivasan A, Liu Z, Yazdani H, Simmons R, et al.
Res Sq
. 2023 Jul;
PMID: 37503167
Introduction: Metformin is the most prescribed medication in Diabetes Mellitus(DM). Metformin has shown to decrease mean platelet volume, with promising antiplatelet effects. High doses of Metformin have also been associated...
8.
Kaltenmeier C, Wang R, Popp B, Geller D, Tohme S, Yazdani H
Cells
. 2022 Jul;
11(14).
PMID: 35883665
Ischemia reperfusion injury (IRI) is a major obstacle in liver resection and liver transplantation. The initial step of IRI is mediated through ischemia which promotes the production of reactive oxygen...
9.
Kaltenmeier C, Yazdani H, Handu S, Popp B, Geller D, Tohme S
Front Immunol
. 2022 Jul;
13:887565.
PMID: 35844608
The innate immune system plays an essential role in the response to sterile inflammation and its association with liver ischemia and reperfusion injury (IRI). Liver IRI often manifests during times...
10.
Hoteit L, Deeb A, Andraska E, Kaltenmeier C, Yazdani H, Tohme S, et al.
Curr Pathobiol Rep
. 2021 Dec;
9(4):107-117.
PMID: 34900401
Purpose Of Review: COVID-19 has rapidly evolved into a global pandemic infecting over two hundred and forty-four million individuals to date. In addition to the respiratory sequelae and systemic infection...